Adipogenesis inhibitory factor
Adipogenesis inhibitory factor Brand names, Adipogenesis inhibitory factor Analogs
Adipogenesis inhibitory factor Brand Names Mixture
- No information avaliable
Adipogenesis inhibitory factor Chemical_Formula
C854H1411N253O235S2
Adipogenesis inhibitory factor RX_link
http://www.rxlist.com/cgi/generic3/oprelvek.htm
Adipogenesis inhibitory factor fda sheet
Adipogenesis inhibitory factor msds (material safety sheet)
Adipogenesis inhibitory factor Synthesis Reference
No information avaliable
Adipogenesis inhibitory factor Molecular Weight
19047.2
Adipogenesis inhibitory factor Melting Point
No information avaliable
Adipogenesis inhibitory factor H2O Solubility
No information avaliable
Adipogenesis inhibitory factor State
Liquid
Adipogenesis inhibitory factor LogP
-0.070
Adipogenesis inhibitory factor Dosage Forms
Powder for solution; Solution (subcutaneous injection)
Adipogenesis inhibitory factor Indication
Increases reduced platelet levels due to chemotherapy
Adipogenesis inhibitory factor Pharmacology
Oprelvekin is indicated for the prevention of severe thrombocytopenia and the reduction of the need for platelet transfusions following myelosuppressive chemotherapy in adult patients with nonmyeloid malignancies who are at high risk of severe thrombocytopenia. The primary hematopoietic activity of Oprelvekin is stimulation of megakaryocytopoiesis and thrombopoiesis. Oprelvekin has shown potent thrombopoietic activity in individuals with compromised hematopoiesis
Adipogenesis inhibitory factor Absorption
No information avaliable
Adipogenesis inhibitory factor side effects and Toxicity
No information avaliable
Adipogenesis inhibitory factor Patient Information
No information avaliable
Adipogenesis inhibitory factor Organisms Affected
Humans and other mammals
